Lexeo Therapeutics (LXEO) - News Mentions

Sign up to add (LXEO) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 2 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 1 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 100%
Lexeo Therapeutics (NASDAQ:LXEO) Given “Outperform” Rating at Royal Bank of Canada
January 22
Analysts Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Target Price at $23.80
January 19
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7
Head-To-Head Analysis: AlloVir (NASDAQ:ALVR) & Lexeo Therapeutics (NASDAQ:LXEO)
January 2
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Rating of “Buy” by Analysts
December 22
Wellington Management Group LLP Increases Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)
December 21
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Acquired by BNP Paribas Financial Markets
December 20
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
December 19
Lexeo Therapeutics : Appoints Kyle Rasback as Chief Financial Officer Form 8 K
December 18
Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart
January 21
Comparing Pluri (NASDAQ:PLUR) & Adverum Biotechnologies (NASDAQ:ADVM)
January 15
Lexeo stock plunges to 52-week low, hits $5.75 amid market challenges
January 15

Month over Month

Est. daily news mentions.

Dec 2024 0
Nov 2024 0
Oct 2024 0
Sep 2024 0

How often is Lexeo Therapeutics mentioned in the news?

Lexeo Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Lexeo Therapeutics performing compared to its industry peers?

Lexeo Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Lexeo Therapeutics in the last month?

There has been no significant change in the number of news mentions for Lexeo Therapeutics' compared to the last month.

Why is it important to track news mentions for Lexeo Therapeutics?

By monitoring mentions in the news for Lexeo Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Lexeo Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Lexeo Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact